Abstract: The disclosed invention relates to a bidirectional shelf assembly which may be used in a single door or double door cabinet. The cabinet may comprise the decontamination chamber of a decontamination unit. The cabinet may comprise a sterilizer and/or washer.

Abstract: The disclosed invention relates to a portable decontamination unit. The invention also relates to a decontamination process. The decontamination unit may be ruggedized for use in hostile environments such as those that may be anticipated for military applications.

Abstract: An oxidizing liquid (20), such as hydrogen peroxide, is vaporized (18) and the vapor is used to deactivate nerve gas, blistering gas, or other biologically active substances such as pathogens, biotoxins, and prions. A second chemical compound (42) in vapor, mist, or fog form is used in conjunction with the oxidizing vapor. In one embodiment, the second chemical preconditions the biologically active substances to be deactivated more efficiently by the oxidizing vapor. In another embodiment, the second chemical boosts the reactivity of the oxidizing vapor. In another embodiment, the other chemical reacts with the oxidizing vapor to form an intermediate compound that deactivates at least some of the biologically active substances.

Abstract: Hydrogen peroxide is vaporized (20) and mixed (30) with ammonia gas in a ratio between 1:1 and 1:0.0001. The peroxide and ammonia vapor mixture are conveyed to a treatment area (10) to neutralize V-type, H-type, or G-type chemical agents, pathogens, biotoxins, spores, prions, and the lip-,e. The ammonia provides the primary deactivating agent for G-type agents with the peroxide acting as an accelerator. The peroxide acts as the primary agent for deactivating V-type and H-type agents, pathogens, biotoxins, spores, and prions. The ammonia acts as an accelerator in at least some of these peroxide deactivation reactions.

Abstract: The disclosed invention relates to a decontamination unit which is energy efficient and may be used to decontaminate a large enclosure such as a multi-room building. The invention also relates to a decontamination process. The decontamination unit may be ruggedized for use in hostile environments such as those that may be anticipated for military applications.

Abstract: A conveyor for moving objects along a path is comprised of a plurality of spaced-apart rollers that define the path of the conveyor. The upper edges of the rollers are aligned to define the surface of the path. Two spaced-apart side rails having inward-facing surfaces define two side boundaries of the path. A barrier assembly is disposed within a gap in one of the side rails for facilitating loading and unloading of objects onto the conveyor from one side of the conveyor. The barrier assembly is comprised of a mounting plate mounted to the conveyor and a barrier pivotally mounted to the mounting plate. The barrier has a wall section generally aligned with the inward-facing surface on one of the side rails. The barrier is movable between a first position wherein the wall section is elevated relative to the upper edges of the roller and a second position wherein the wall section is disposed below the upper edge of the rollers.

Abstract: The present invention provides a spray arm assembly comprised of a tubular member rotatable about a fixed axis. The tubular member has an internal passage and a central axis extending a length of the tubular member. A nozzle assembly is attachable to an end of the tubular member and fluidly communicates with the internal passage of the tubular member. The nozzle assembly is comprised of an insert attachable to the tubular member in a predetermined position. A nozzle body has an aperture therein defining a spray orifice. The nozzle body is mountable to the insert in one of a plurality of positions wherein the spray orifice has an orientation based upon a position of the nozzle body relative to the insert. A fastening means is provided for fastening the insert and the nozzle body together in one of the plurality of positions.

Abstract: A self-cleaning filter for a washing apparatus. Water entering a filter assembly travels along a spiral pathway that facilitates the separation of heavy solid debris from the water. A filter element prevents both light and heavy solid debris from entering a conduit leading to spray nozzles, thereby preventing clogging of the nozzles. In a filter cleaning operation, solid debris is removed from the filter assembly.

Abstract: The present invention provides a washer for washing articles. A housing of the washer defines a chamber. A partition divides the chamber into an upper compartment and a lower compartment. An outer peripheral edge of the partition generally conforms to side walls of the housing such that a gap is formed between the edge of the partition and the side walls of the housing. A blower assembly disposed in the upper compartment has a first air inlet, a second air inlet and an air outlet. The first air inlet fluidly communicates with the lower compartment. The second air inlet fluidly communicates with an external air inlet line. The air outlet fluidly communicates with the upper compartment. An impeller is provided to circulate air from the lower compartment and from the air inlet line into the upper compartment. A heating means heats the air in the upper compartment.

Abstract: An integrated duct system is utilized to admit an antimicrobial vapor into a vehicle to decontaminate the contents and surfaces of the vehicle and subsequently to remove the vapor. The ducts comprise an air conditioning and/or heating duct, a decontamination duct for admitting an antimicrobial vapor, an auxiliary circulation duct for diffusing the vapor throughout the vehicle, and an aeration duct for removing the vapor from the vehicle, as well as a catalytic converter for detoxifying the antimicrobial vapor before removal. The integrated decontamination system is suitable for the chemical or biological decontamination of vehicles, provides enhanced vapor delivery and distribution on a rapid basis and also provides for rapid aeration for removing the antimicrobial vapor.

Abstract: A cartridge holder (30) for an automated endoscope reprocessor (10) is mounted on a movable rack (14). As the rack is wheeled into the chamber, a connector (164) on the cartridge holder (164) automatically makes a fluid connection with a connection port (158) within the chamber. The cartridge holder includes a base (42) and a lid (44), which is pivotally connected to the base by a hinge (110). A cartridge (40) holding a dose of a disinfectant concentrate or reagents is positioned in a well (50) defined by the base and the lid closed. Water flows through the cartridge holder via a fluid passageway (A) defined in part by the lid and in part by the hinge. The water mixes with the concentrate or reagents and the resulting disinfectant solution passes out of a lower end (205) of the cartridge into the well. The solution flows upwardly, around the cartridge, through an annular space (232) between the cartridge and the well, disinfecting the well in the process.

Abstract: When microbial contamination is introduced into a room (20*) of an enclosure, such as a building, an HVAC system including supply ductwork (16) and a return ductwork (34) is decontaminated with hydrogen peroxide vapor. A decontamination controller (46) operates controllable baffles (22) at outlet registers (20), temporary controllable baffles (44) at inlet registers (30), and a blower system (10) to circulate hydrogen peroxide vapor from hydrogen peroxide vapor generators (42) through the ductwork in both forward and reverse directions. Further, at least portions of the baffles are closed to create dwell times in which the hydrogen peroxide vapor resides in the ductwork with minimal or turbulent flow.

Abstract: An integrated duct system is utilized to admit an antimicrobial vapor into a vehicle to decontaminate the contents and surfaces of the vehicle and subsequently to remove the vapor. The ducts comprise an air conditioning and/or heating duct, a decontamination duct for admitting an antimicrobial vapor, an auxiliary circulation duct for diffusing the vapor throughout the vehicle, and an aeration duct for removing the vapor from the vehicle, as well as a catalytic converter for detoxifying the antimicrobial vapor before removal. The integrated decontamination system is suitable for the chemical or biological decontamination of vehicles, provides enhanced vapor delivery and distribution on a rapid basis and also provides for rapid aeration for removing the antimicrobial vapor.

Abstract: Hydrogen peroxide is vaporized (20) and mixed (30) with ammonia gas in a ratio between 1:1 and 1:0.0001. The peroxide and ammonia vapor mixture are conveyed to a treatment area (10) to neutralize V-type, H-type, or G-type chemical agents, pathogens, biotoxins, spores, prions, and the like. The ammonia provides the primary deactivating agent for G-type agents with the peroxide acting as an accelerator. The peroxide acts as the primary agent for deactivating V-type and H-type agents, pathogens, biotoxins, spores, and prions. The ammonia acts as an accelerator in at least some of these peroxide deactivation reactions.

Abstract: Hydrogen peroxide is vaporized (20) and mixed (30) with ammonia gas in a ratio between 1:1 and 1:0.0001. The peroxide and ammonia vapor mixture are conveyed to a treatment area (10) to neutralize V-type, H-type, or G-type chemical agents, pathogens, biotoxins, spores, prions, and the like. The ammonia provides the primary deactivating agent for G-type agents with the peroxide acting as an accelerator. The peroxide acts as the primary agent for deactivating V-type and H-type agents, pathogens, biotoxins, spores, and prions. The ammonia acts as an accelerator in at least some of these peroxide deactivation reactions.

Abstract: Hydrogen peroxide is vaporized (20) and mixed (30) with ammonia gas in a ratio between 1:1 and 1:0.0001. The peroxide and ammonia vapor mixture are conveyed to a treatment area (10) to neutralize V-type, H-type, or G-type chemical agents, pathogens, biotoxins, spores, prions, and the lip-,e. The ammonia provides the primary deactivating agent for G-type agents with the peroxide acting as an accelerator. The peroxide acts as the primary agent for deactivating V-type and H-type agents, pathogens, biotoxins, spores, and prions. The ammonia acts as an accelerator in at least some of these peroxide deactivation reactions.

Abstract: An integrated duct system is utilized to admit an antimicrobial vapor into a vehicle to decontaminate the contents and surfaces of the vehicle and subsequently to remove the vapor. The ducts comprise an air conditioning and/or heating duct, a decontamination duct for admitting an antimicrobial vapor, an auxiliary circulation duct for diffusing the vapor throughout the vehicle, and an aeration duct for removing the vapor from the vehicle, as well as a catalytic converter for detoxifying the antimicrobial vapor before removal. The integrated decontamination system is suitable for the chemical or biological decontamination of vehicles, provides enhanced vapor delivery and distribution on a rapid basis and also provides for rapid aeration for removing the antimicrobial vapor.

Abstract: A tunnel washer that includes fluid exhaust paths that are optimized to minimize fluid transfer between chambers of the washer and minimize heat loss from each chamber of the washer. The fluid exhaust paths also facilitate uniform vapor evacuation from each chamber of the washer. The tunnel washer also includes spaced-apart double wall curtains for isolating chambers of the tunnel washer to prevent fluid and heat transfer therebetween, and to the exterior of the tunnel washer. The double wall curtains include surfaces that inhibit the curtains from sticking together during operation of the tunnel washer. The tunnel washer also includes an air manifold that provides uniform drying efficiency for articles of varying dimensions.

Abstract: An oxidizing liquid (20), such as hydrogen peroxide, is vaporized (18) and the vapor is used to deactivate nerve gas, blistering gas, or other biologically active substances such as pathogens, biotoxins, and prions. A second chemical compound (42) in vapor, mist, or fog form is used in conjunction with the oxidizing vapor. In one embodiment, the second chemical preconditions the biologically active substances to be deactivated more efficiently by the oxidizing vapor. In another embodiment, the second chemical boosts the reactivity of the oxidizing vapor. In another embodiment, the other chemical reacts with the oxidizing vapor to form an intermediate compound that deactivates at least some of the biologically active substances.